Deckers Outdoor Corporation

▲ Bull Case

• ◆HOKA international reaccelerates to 20%+ growth from 26.8% FY2026 base, forcing consensus re-rate from 12% to 15%+ HOKA CAGR. Two consecutive quarters >20% international growth would shift FY2029 EPS from ~$9 to $11+, implying stock price above $175 even at same 15x multiple.
• ◆$5B buyback authorization compounds per-share value independent of operating performance. Retiring 6-7% of shares annually for 4-5 years at trough prices creates ~30% cumulative per-share earnings accretion by FY2031 from buyback math alone.
• ◆Tariff resolution (Vietnam footwear exemption feasible via ongoing US-Vietnam trade negotiations) unlocks gross margin recovery to 58%+, removing primary bear thesis objection and potentially triggering 3-5x multiple expansion to 18-20x P/E, valuing stock at $180/share at $10 FY2029 EPS.

▼ Bear Case

• ◆HOKA decelerates structurally to <8% growth as On Running (ONON) establishes APAC category leadership first. HOKA growth floor settles at near-market rates, losing growth premium narrative. At 7% HOKA CAGR, FY2031 HOKA revenue is ~$3.6B vs $4.3B base case, compressing intrinsic value to ~$100/share.
• ◆Tariff escalation causes permanent gross margin reset. If Vietnam tariff rates rise further or supply chain diversification costs exceed guidance, gross margins settle at 55-55.5% rather than recovering to 57.5%+. Every 100 bps gross margin miss = ~$4.5/share value loss; 200 bps permanent miss = ~$9/share value destruction.
• ◆CEO Caroti makes a large value-destructive acquisition. With $5B in buyback authorization and $1.9B cash, a board-approved M&A deal at the wrong price would destroy the capital allocation thesis. Prior missteps (Sanuk, Koolaburra) are cautionary; Caroti has no precedent as standalone CEO to validate M&A discipline.

“The core consensus debate is whether HOKA is a transient growth brand (Crocs 2.0) or a durable platform (Lululemon 2.0). Skeptics argue HOKA's 50% CAGR growth phase is over and at $2.6B scale will normalize to 8-10%, facing competitive pressure from well-capitalized On Running and fashion-cycle risk to the cushion aesthetic. Bulls counter that HOKA is a platform with a clinical/PT recommendation moat distinct from fashion, and international growth at 26.8% in FY2026 far exceeds what a decelerating brand would show—management's FY2030 framework implies low-double-digit normalized growth is premium. The catalyst resolving this debate: 2-3 consecutive quarters of HOKA international growth >15% YoY would shift narrative from 'decelerating' to 'next global running franchise'.”

• ◆HOKA Q1/Q2 FY2027 international growth >20% YoY (Q1-Q2 FY2027, Jul-Sep 2026): HIGH impact — re-rates growth narrative to bull case
• ◆Tariff policy announcement—footwear exemption or Vietnam rollback (any point 2026): MEDIUM-HIGH impact — removes largest bear overhang from 60% drawdown
• ◆FY2027 EPS guidance beat ($7.75+ vs $7.33 consensus) (Q2 FY2027 earnings, Aug 2026): HIGH impact — validates conservative guidance posture
• ◆Aggressive buyback disclosure ($250M+ in a quarter) (any quarterly report): MEDIUM impact — signals management conviction at trough prices
• ◆UGG international breakout ($700M+ international in FY2027) (Q3 FY2027 holiday season, Dec 2026): MEDIUM impact — broadens narrative beyond HOKA
• ◆CEO Caroti 3-year plan or investor day announcement (any point FY2027): MEDIUM impact — market wants strategic vision beyond FY2030 framework

• ◆HOKA growth deceleration to <8% sustained (HIGH magnitude, 12-24 month timeline, 17% probability): Structural deceleration as On Running establishes APAC leadership, invalidating growth thesis and compressing intrinsic value.
• ◆Tariff escalation (Vietnam >50%) + no mitigation (HIGH magnitude, near-term, 10% standalone probability): Further tariff increases beyond 46% current rates or supply chain diversification costs exceeding guidance compress gross margins permanently.
• ◆Consumer discretionary recession (MEDIUM magnitude, 12-18 months, 20% probability): Macroeconomic downturn reduces discretionary footwear demand and price realization.
• ◆HOKA brand dilution via lifestyle overexpansion (MEDIUM-HIGH magnitude, 2-4 years, 25% long-term probability): Performance identity dilution as HOKA expands into casual/lifestyle undermines clinical moat.
• ◆USD strengthening (MEDIUM magnitude, ongoing, 40% probability): Currency headwinds reduce reported international revenue and margin on USD translation.
• ◆CEO Caroti large M&A at poor prices (MEDIUM magnitude, 12-24 months, 10-15% probability): Board-approved M&A deal above intrinsic value destroys shareholder returns; Sanuk/Koolaburra failures precedent.
• ◆UGG fashion cycle reversal (HIGH if occurs, 2-4 years, 15% probability): Fashion-cycle peak for UGG brand creates revenue decline and removes cash cow funding HOKA growth investment and buybacks.